Ragaglitazar, a PPARalpha and PPARgamma Agonist, is used potentially for diabetics.

222834-30-2

C25H25NO5

419.47

NN-622;(-)-DRF-2725;NNC-61-0029;NNC61-0029;NN 622;NNC 61-0029;Ragaglitazar

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years